Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Intranasal RX0041-002 in Hepatic Impairment
NCT02775981Phase 1Completed
- Sponsor
- Pharmaceutical Project Solutions
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of nifedipine in procedural pain (2 arms), sponsored by Pharmaceutical Project Solutions. Primary endpoints: Peak Plasma Concentration at 32 hours and Area Under the Curve at 32 hours. Started Feb 2016; status: completed.
02
Drugs
nifedipine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02775981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775981.